Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-15-003056
Filing Date
2015-05-22
Accepted
2015-05-22 16:30:29
Documents
2
Period of Report
2015-05-21

Document Format Files

Seq Description Document Type Size
1 formthree.html 3  
1 formthree.xml 3 3476
2 EXHIBIT 24.1 exh_241.htm EX-24 7008
  Complete submission text file 0001171843-15-003056.txt   11817
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A0 V5G 4W8
Business Address
GANNON STEVEN (Reporting) CIK: 0001643085 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 15886988